Over 7 Million Americans Successfully Vaccinated against Covid-19, According to HHS – Shiv Telegram Media

Title: Slower Uptake of Updated Covid-19 Vaccines Raises Concerns in the U.S.

The rollout of the updated Covid-19 vaccines this year has been slower compared to last year, leading to concerns about the overall vaccination rate in the United States. So far, over 7 million Americans have received a dose of the latest vaccines, but experts are worried that this number is significantly lower than last year.

The Centers for Disease Control and Prevention (CDC) has recommended vaccines from Moderna and Pfizer/BioNTech for everyone aged 6 months and older since September 12. Additionally, an updated vaccine from Novavax has become available this month, recommended for people aged 12 and over. These vaccines have been updated to specifically target currently circulating coronavirus variants.

Last year, by October 12, about six weeks after CDC approval, more than 18 million people had received a dose of the bivalent Covid-19 booster. This stark difference in numbers has raised concerns about the potential reasons behind the lower uptake of the updated vaccines this year.

One possible explanation could be distribution delays and difficulties in finding doses or insurance coverage. It is also concerning that the vaccines might not be reaching children. Approximately 710,000 vaccines have been ordered through the CDC’s Vaccines for Children program, but experts worry that this number falls short of the actual demand.

To address these issues, the Biden-Harris Administration is actively collaborating with manufacturers and distributors to ensure efficient vaccine delivery to vaccination sites across the country. Significant efforts are being made to improve distribution and availability, especially for vulnerable populations and children.

Another worrisome trend is the lower uptake of the new Covid-19 shot among older adults, as well as the lack of vaccination against flu and respiratory syncytial virus (RSV). This year, for the first time in history, the U.S. has vaccines available against Covid-19, flu, and RSV. All three vaccines have proven effective in preventing severe illness, hospitalization, or death among individuals with underlying health conditions.

Despite the concerns surrounding vaccine uptake, it is noteworthy that almost 14 million doses have been shipped to pharmacies and other vaccination sites. Additionally, 91% of Americans aged 12 and older can access vaccines within a five-mile radius of their residences. These figures indicate significant progress, but efforts must be intensified to ensure widespread vaccination coverage.

In conclusion, the slower uptake of the updated Covid-19 vaccines in the U.S. raises concerns about the overall vaccination rate. Efforts are underway to address distribution challenges and reach vulnerable populations, including children and older adults. The availability of vaccines against Covid-19, flu, and RSV presents a unique opportunity to protect individuals with underlying health conditions, and it is essential to promote their uptake and ensure comprehensive vaccination coverage nationwide.